Research Article
Circulating MicroRNAs in Elderly Type 2 Diabetic Patients
Figure 4
Heat maps showing circulating microRNAs that were differentially expressed in plasma samples from (a) R and NR patients at baseline (t0), prior to the addition of sitagliptin to the maximum-dose metformin regimen; (b) R at t0 and after 15 months of sitagliptin (t15); (c) NR patients at t15 and t0; and (d) R and NR patients at t15.
| (a) |
| (b) |
| (c) |
| (d) |